(Q28373416)

English

EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease

scientific article

In more languages

Statements

scholarly article

0 references

EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease (English)

0 references

0 references

author name string

M K Angelopoulou

1

0 references

T P Vassilakopoulos

2

0 references

M P Siakantaris

3

0 references

F N Kontopidou

4

0 references

V A Boussiotis

5

0 references

C Papavassiliou

6

0 references

C Kittas

7

0 references

G A Pangalis

8

0 references

language of work or name

0 references

publication date

March 2000

0 references

Leukemia & Lymphoma

0 references

37

0 references

1-2

0 references

131-43

0 references

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.3109/10428190009057636

21 April 2017

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

1 reference

https://api.crossref.org/works/10.3109/10428190009057636

21 April 2017

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.3109/10428190009057636

21 April 2017

Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Critical Evaluation of Laparotomy and Splenectomy in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F10428190009057636

21 January 2018

Identifiers

10.3109/10428190009057636

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28373416&oldid=1613247508"